Rampart Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,562
Closed -$420K 112
2020
Q3
$420K Sell
1,562
-4,153
-73% -$1.12M 0.27% 92
2020
Q2
$1.5M Buy
5,715
+3,579
+168% +$955K 0.25% 108
2020
Q1
$485K Sell
2,136
-3,768
-64% -$1.03M 0.23% 92
2019
Q4
$1.78M Sell
5,904
-1,054
-15% -$290K 0.22% 135
2019
Q3
$1.67M Buy
6,958
+136
+2% +$37.3K 0.21% 146
2019
Q2
$1.93M Sell
6,822
-400
-6% -$109K 0.23% 136
2019
Q1
$2.07M Buy
7,222
+4,462
+162% +$1.29M 0.24% 130
2018
Q4
$725K Sell
2,760
-3,373
-55% -$927K 0.2% 116
2018
Q3
$1.68K Sell
6,133
-4,339
-41% -$1.13M ﹤0.01% 485
2018
Q2
$2.49M Buy
10,472
+1,385
+15% +$321K 0.24% 120
2018
Q1
$2M Buy
+9,087
New +$2.13M 0.19% 163
2017
Q4
Sell
-3,624
Closed -$688K 504
2017
Q3
$688K Buy
3,624
+223
+7% +$42.4K 0.23% 100
2017
Q2
$640K Buy
3,401
+2,668
+364% +$479K 0.23% 98
2017
Q1
$121K Buy
+733
New +$117K 0.04% 124

Other funds holding ELV

Rampart Investment Management's ELV Position: Q4 2020 in Review

Rampart Investment Management sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 1,562 shares — an estimated $420K sold.

Rampart Investment Management first reported a position in ELV in Q1 2017 and held it in 14 quarters. The position peaked at $2.49M in Q2 2018. 1,171 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Rampart Investment Management reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 1,562 Elevance Health shares in Q4 2020, an estimated $420K.
  • Rampart Investment Management first reported a position in Elevance Health in Q1 2017 and held it in 14 quarters.
  • Rampart Investment Management's Elevance Health position peaked at $2.49M in Q2 2018.
  • 1,171 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.